Treatments for Covid-19

Covid-19 Treatments that Already Exist

Ivermectin in Treating Covid-19

Source: Database of all ivermectin COVID-19 studies – www.c19ivermectin.com – (constantly updated)

From “Front Line Doctors” – FLCC Alliance

We regard ivermectin as a core medication in the prevention and treatment of COVID-19. For comprehensive information on ivermectin please refer to our Review of the Emerging Evidence Supporting the Use of Ivermectin in the Prophylaxis and Treatment of COVID-19 and the included references.”

For questions about the safety of this medicine, you can read the expert review of over 350 articles on the medical safety profile of ivermectin that was conducted by a toxicologist for Medincell, which reported that “No safety concern was anticipated that would prevent health authorities from assessing the use of Ivermectin against COVID-19.” The review is available at www.medincell.com/ivermectin

A more recent paperMeta-analysis of Randomized Trials of Ivermectin to treat SARS-CoV-2 Infection was accepted for publication July 6, 2021, by Oxford University Press on behalf of the Infectious Diseases Society of America. This study was done by Dr. Andrew Hill and the team that researched ivermectin’s efficacy in COVID-19 treatment for the WHO. The data is overwhelmingly positive and was discussed in detail by Dr. Pierre Kory on the FLCCC’s July 7, 2021, Weekly Update.

Another recent paperIvermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines was published online June 17, 2021, by the American Journal of Therapeutics. It concludes, “Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”

>> For more information on the use of Ivermectin in the proactive treatment of the Coronavirus Covid-19, please visit https://covid19criticalcare.com/ivermectin-in-covid-19/

Update: The FLCCC Alliance’s “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” has been peer-reviewed, accepted, and published on May 1, 2021, in the  American Journal of Therapeutics!

Hydroxychloroquine When Used With Zinc and Azithromycin is Effective in Treating Covid-19

From Yahoo News:

A new study shows that the controversial drug hydroxychloroquine touted by former President Donald Trump increased the survival rate of severely ill coronavirus patients.

The observational study, published by medRxiv, found that antimalarial drug hydroxychloroquine, along with zinc, could increase the coronavirus survival rate by as much as nearly 200% if distributed at higher doses to ventilated patients with a severe version of the illness.

“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the study’s conclusion states.

>> Read the full article: https://news.yahoo.com/study-shows-hydroxychloroquine-zinc-treatments-210300816.html

From State of the Nation, Feb 25, 2021:

The American Journal Of Medicine Now Recommends HCQ For COVID19

Written by The American Journal of Medicine


As of Jan 2021, The American Journal of Medicine now recommends Hydroxychloroquine, Azithromycin, and Zinc  for the treatment of Covid 19 outpatients.

>> Read the full article: https://stateofthenation.co/?p=51305

%d bloggers like this: